-
Je něco špatně v tomto záznamu ?
Investigation of tumour supressor protein p53 in renal cell carcinoma patients
I. Hodorova, P. Solar, J. Mihalik, J. Vecanova, M. Adamkov, S. Rybarova
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
- MeSH
- karcinom z renálních buněk chemie patologie MeSH
- ledviny chemie MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádorový supresorový protein p53 analýza MeSH
- nádory ledvin chemie patologie MeSH
- stupeň nádoru MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Investigation of p53 immunoreactivity in formalin-fixed paraffin-embedded tissues of normal renal tissue and renal cell carcinoma with respect to histopathologic subtype and nuclear grade of RCC. METHODS: 42 tissue sections of RCC and 5 samples of normal renal tissue were stained for p53 expression using immunohistochemical assay. The results were analyzed in relation to nuclear grade and histopathologic subtype. RESULTS: In total, p53 expression was found to be 4 to 5 times higher (30.8%) in other types of RCC than in the clear-cell type of RCC (6.9%). Further, there was no statistically significant difference in p53 overexpression among the histopathologic subtypes (P>0.05, P=0.063). No association was found between the expression of p53 and nuclear grade (P>0.05, P=0.17). Interestingly, our study also showed weak cytoplasmic positivity in renal tubular epithelium. CONCLUSION: Our findings suggest that p53 might play an important role in tumour development or progression and it might be used as a new predictor and therapeutic target for RCC.
Department of Anatomy P J Safarik University Faculty of Medicine Kosice Slovak Republic
Department of Cell Biology P J Safarik University Faculty of Science Kosice Slovak Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15026722
- 003
- CZ-PrNML
- 005
- 20150818085836.0
- 007
- ta
- 008
- 150811s2014 xr a f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2012.035 $2 doi
- 035 __
- $a (PubMed)23073516
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Hodorová, Ingrid $u Department of Anatomy, P. J. Safarik University, Faculty of Medicine, Kosice, Slovak Republic $7 xx0278058
- 245 10
- $a Investigation of tumour supressor protein p53 in renal cell carcinoma patients / $c I. Hodorova, P. Solar, J. Mihalik, J. Vecanova, M. Adamkov, S. Rybarova
- 520 9_
- $a BACKGROUND: Investigation of p53 immunoreactivity in formalin-fixed paraffin-embedded tissues of normal renal tissue and renal cell carcinoma with respect to histopathologic subtype and nuclear grade of RCC. METHODS: 42 tissue sections of RCC and 5 samples of normal renal tissue were stained for p53 expression using immunohistochemical assay. The results were analyzed in relation to nuclear grade and histopathologic subtype. RESULTS: In total, p53 expression was found to be 4 to 5 times higher (30.8%) in other types of RCC than in the clear-cell type of RCC (6.9%). Further, there was no statistically significant difference in p53 overexpression among the histopathologic subtypes (P>0.05, P=0.063). No association was found between the expression of p53 and nuclear grade (P>0.05, P=0.17). Interestingly, our study also showed weak cytoplasmic positivity in renal tubular epithelium. CONCLUSION: Our findings suggest that p53 might play an important role in tumour development or progression and it might be used as a new predictor and therapeutic target for RCC.
- 650 _2
- $a karcinom z renálních buněk $x chemie $x patologie $7 D002292
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ledviny $x chemie $7 D007668
- 650 _2
- $a nádory ledvin $x chemie $x patologie $7 D007680
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a stupeň nádoru $7 D060787
- 650 _2
- $a nádorový supresorový protein p53 $x analýza $7 D016159
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Solár, Peter, $d 1970- $7 xx0140463 $u Department of Cell Biology, P. J. Safarik University, Faculty of Science, Kosice, Slovak Republic
- 700 1_
- $a Mihalík, Jozef $7 _AN032180 $u Department of Anatomy, P. J. Safarik University, Faculty of Medicine, Kosice, Slovak Republic
- 700 1_
- $a Vecanová, Janka $7 _AN032179 $u Department of Anatomy, P. J. Safarik University, Faculty of Medicine, Kosice, Slovak Republic
- 700 1_
- $a Adamkov, Marian $7 xx0070157 $u Institute of Histology and Embryology, Comenius University, Jessenius Faculty of Medicine, Martin, Slovak Republic
- 700 1_
- $a Rybárová, Silvia, $d 1959- $7 stk2008428612 $u Department of Anatomy, P. J. Safarik University, Faculty of Medicine, Kosice, Slovak Republic
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 158, č. 1 (2014), s. 44-49
- 856 41
- $u http://biomed.papers.upol.cz/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20150811 $b ABA008
- 991 __
- $a 20150817092007 $b ABA008
- 999 __
- $a ok $b bmc $g 1087932 $s 909758
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 158 $c 1 $d 44-49 $e 20120601 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20150811